A new class of potent non-imidazole H3 antagonists:: 2-aminoethylbenzofurans

被引:80
作者
Cowart, M [1 ]
Pratt, JK [1 ]
Stewart, AO [1 ]
Bennani, YL [1 ]
Esbenshade, TA [1 ]
Hancock, AA [1 ]
机构
[1] Abbott Labs, Dept Neurosci Res, Abbott Pk, IL 60064 USA
关键词
D O I
10.1016/j.bmcl.2003.11.032
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
2-Aminoethylbenzofurans constitute a new class of H-3 antagonists that are more rotationally constrained than most previously reported H-3 antagonists. They retain high potency at human and rat receptors, with efficient CNS penetration observed in 35. The SAR of the basic amine moiety was compared in three different series of analogues. The greatest potency was found in analogues bearing a 2-methylpyrrolidine, a 2,5-dimethylpyrrolidine, or a 2,6-dimethylpiperidine. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:689 / 693
页数:5
相关论文
共 33 条
[11]  
GANELLIN CR, 1982, PHARM HISTAMINE RECE, P11
[12]  
HANCOCK AA, 2003, 225 ACS NAT M NEW OR
[13]  
Hill SJ, 1997, PHARMACOL REV, V49, P253
[14]   Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells [J].
Hofstra, CL ;
Desai, PJ ;
Thurmond, RL ;
Fung-Leung, WP .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (03) :1212-1221
[15]   Therapeutic potential histamine H3 receptor agonists and antagonists [J].
Leurs, R ;
Blandina, P ;
Tedford, C ;
Timmerman, H .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (05) :177-183
[16]  
LEURS R, 1998, HISTAMINE H3 RECEPTO, V30
[17]   Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists [J].
Liedtke, S ;
Flau, K ;
Kathmann, M ;
Schlicker, E ;
Stark, H ;
Meier, G ;
Schunack, W .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 (01) :43-50
[18]   Inhibition and induction of cytochrome P450 and the clinical implications [J].
Lin, JH ;
Lu, AYH .
CLINICAL PHARMACOKINETICS, 1998, 35 (05) :361-390
[19]   Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow [J].
Liu, CL ;
Ma, XJ ;
Jiang, XX ;
Wilson, SJ ;
Hofstra, CL ;
Blevitt, J ;
Pyati, J ;
Li, XB ;
Chai, WY ;
Carruthers, N ;
Lovenberg, TW .
MOLECULAR PHARMACOLOGY, 2001, 59 (03) :420-426
[20]  
Lovenberg TW, 2000, J PHARMACOL EXP THER, V293, P771